CD8A and neoplasm: YUMMER1.7 implantedAgRSR-LSL-EYFP mice were intratumorally injected with tamoxifen, and allCD8+EYFP+, and a proportion of the CD8+EYFP- cells from the tumor and lymph nodewere processed through bulk TCR-seq 8 days after intratumoral tamoxifenadministration (Fig. 4D).